SLXN
Price
$4.06
Change
+$0.20 (+5.18%)
Updated
Oct 8, 11:47 AM (EDT)
Capitalization
12.07M
SPRY
Price
$10.33
Change
+$0.06 (+0.58%)
Updated
Oct 7 closing price
Capitalization
1.02B
29 days until earnings call
Interact to see
Advertisement

SLXN vs SPRY

Header iconSLXN vs SPRY Comparison
Open Charts SLXN vs SPRYBanner chart's image
Silexion Therapeutics
Price$4.06
Change+$0.20 (+5.18%)
Volume$1K
Capitalization12.07M
ARS Pharmaceuticals
Price$10.33
Change+$0.06 (+0.58%)
Volume$1.94M
Capitalization1.02B
SLXN vs SPRY Comparison Chart in %
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLXN vs. SPRY commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLXN is a StrongBuy and SPRY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (SLXN: $3.86 vs. SPRY: $10.33)
Brand notoriety: SLXN and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLXN: 12% vs. SPRY: 69%
Market capitalization -- SLXN: $12.07M vs. SPRY: $1.02B
SLXN [@Biotechnology] is valued at $12.07M. SPRY’s [@Biotechnology] market capitalization is $1.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLXN’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • SLXN’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, SPRY is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLXN’s TA Score shows that 5 TA indicator(s) are bullish while SPRY’s TA Score has 5 bullish TA indicator(s).

  • SLXN’s TA Score: 5 bullish, 3 bearish.
  • SPRY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SPRY is a better buy in the short-term than SLXN.

Price Growth

SLXN (@Biotechnology) experienced а +13.53% price change this week, while SPRY (@Biotechnology) price change was +2.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.02%. For the same industry, the average monthly price growth was +17.86%, and the average quarterly price growth was +85.73%.

Reported Earning Dates

SPRY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+8.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.02B) has a higher market cap than SLXN($12.1M). SPRY YTD gains are higher at: -2.085 vs. SLXN (-87.197). SLXN has higher annual earnings (EBITDA): -17.81M vs. SPRY (-59.34M). SPRY has more cash in the bank: 240M vs. SLXN (3.47M). SPRY has less debt than SLXN: SPRY (1.66M) vs SLXN (3.7M). SPRY has higher revenues than SLXN: SPRY (112M) vs SLXN (0).
SLXNSPRYSLXN / SPRY
Capitalization12.1M1.02B1%
EBITDA-17.81M-59.34M30%
Gain YTD-87.197-2.0854,182%
P/E RatioN/A151.25-
Revenue0112M-
Total Cash3.47M240M1%
Total Debt3.7M1.66M223%
TECHNICAL ANALYSIS
Technical Analysis
SLXNSPRY
RSI
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
12%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
30%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
37%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
28%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
53%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 14 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
50%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KGS34.520.97
+2.89%
Kodiak Gas Services
BTBD1.880.03
+1.62%
BT Brands
TOST37.170.22
+0.60%
Toast
ARVN9.30-0.32
-3.33%
Arvinas
GSIT4.62-0.20
-4.15%
GSI Technology

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
+0.58%
LPCN - SPRY
63%
Loosely correlated
+0.62%
ANAB - SPRY
36%
Loosely correlated
-1.26%
KROS - SPRY
34%
Loosely correlated
+0.19%
REPL - SPRY
31%
Poorly correlated
-0.64%
NUVL - SPRY
29%
Poorly correlated
-0.56%
More